Active Implantable Medical Devices Market by Product Type (Pacemaker, Implantable Cardioverter Defibrillator, Cardiac Resynchronization Therapy Devices, Neurostimulator, Drug Infusion Pump, Implantable Loop Recorder, Cochlear Implant, and others), and by Region - Global Forecast to 2025

Active Implantable Medical Devices Market Insights

Active implantable medical devices are medical devices totally or partially introduced into the body by a surgical procedure in a natural orifice and remains in that position afterward procedures as well. Active medical devices function by relying on electrical energy or any other power source, which is not generated by the human body. Active implantable medical devices fall into highest risk categories of medical devices listing of the U.S. Food & Drug Administration (FDA). Active implantable medical devices include implantable pacemaker, cochlear implants, implantable defibrillators, drug infusion pumps, neurostimulator, cardiac resynchronization therapy devices, and others. Active implantable medical devices play a significant role in management of a number of diseases such as cardiovascular devices, Parkinson’s disease, epilepsy, spasticity, and patients with hearing or visual impairment. Pacemakers and implantable cardioverter defibrillators (ICDs) are significant components in the management of cardiovascular conditions. Strong magnetic field used in MRI procedures could affect the normal traditional pacemaker functions, however, with advent of MRI compatible pacemakers patients can undergo MRI scans safely, which is expected to increase the adoption rate of pacemakers. For instance, magnetic resonance imaging (MRI) compatible pacemakers, and leadless pacemakers have been introduced in the market since 2011 by Medtronic, and BIOTRONIK

Advancements in technology in the product space and new product launches is expected to boost growth of the active implantable medical devices market

Leading players in the market are focusing on development and launching of new products in order to remain competitive in the market and retain their market share. Initially, these devices were large in size, however, miniaturization of pacemakers and ICDs has simplified the implantation procedure and miniaturization of the products reflects the continuous innovation in the products. This is expected to fuel demand for such products, in turn reflecting growth of the market. For instance, Medtronic’s first leadless pacemaker Micra TPS was approved by the U.S. Food & Drug Administration in 2016 and is known to be the smallest pacemaker. Other innovations such as cardiac contractility modulation, and wireless pacing are expected to positively impact growth of the active implantable medical devices market. Implantable continuous glucose monitoring (Sensonic’s Eversense CGM with implantable sensor, which lasts up to 90 days), and implantable infusion pumps are also expected to propel market growth. Introduction of wireless technology and mobile connectivity has further led to increased functions and effectiveness of these devices. For instance, Cochlear Ltd. collaborated with Apple, Inc. to offer cochlear implants with iPhone connectivity, which was launched in July 2017.

The global active implantable medical devices market was valued at US$ 16,721.2 million in 2016 and is expected to witness a robust CAGR of 5.4% over the forecast period (2017–2025).

Figure 1. Global Active Implantable Medical Devices Market, by Region - 2016 (US$ Mn)

active implantable medical devices market

Source: Coherent Market Insights Analysis (2017)

Rising prevalence of cardiovascular, chronic pain diseases, and hearing disorders is expected to boost growth of the active implantable medical devices market over the forecast period

Increasing global prevalence of cardiovascular system diseases, chronic pain diseases, and associated co morbidities is expected to have a positive impact on the growth of the market. According to the World Health Organization (WHO), around 17 million people die annually from cardiovascular diseases. According to the Centers for Disease Control and Prevention (CDC), 2017, 2.7 to 6.1 million people in the U.S. are suffering from atrial fibrillation, which is the most common type of heart arrhythmia. Prevalence of neurological disorders such as Parkinson’s disease, epilepsy, essential tremors, and dystopia is reported to be high in developed and emerging economies such as India. For instance, around 50,000 people are diagnosed with Parkinson’s disease, annually, in the U.S. according to National Institute of Health (NIH), 2013 data. Neurostimulation is effective in the treatment of these neurological diseases, which is expected to support growth of implantable medical devices market over the forecast period.

However, restraining factors for the market growth are risks associated with use of active implantable medical devices, which are infection at the surgical site and sensitivity to the device material. Furthermore, failure to deliver therapy when needed or receiving extra therapy when not necessary is another factor adversely affecting growth of the market. Active implantable medical devices fall into highest risk category of medical device listing of the U.S. FDA and are subjected to strict scrutiny highly focused on security and privacy which has resulted in various product recalls. For instance, recall of about 500,000 pacemakers manufactured by St. Jude Medical, Inc. in August 2017, due to hacking concerns. Such events could hamper the growth of active implantable medical devices market over the forecast period.

Some major players operating in the active implantable medical devices market are Cochlear Limited, Boston Scientific Corporation, Medtronic Plc, LivaNova Plc, Abbott Laboratories, Sonova Holding AG, William Demant holding A/S, Nurotron Biotechnology Co., Ltd., and Med-EL.

Active implantable medical devices such as cardiac pacemaker systems, cochlear implants, implantable infusion pumps, cardiac resynchronization therapy devices aid in improving patient’s health and outcome of the medical treatment. Active implantable medical devices are prosthetic devices, which provide support in functioning of organs. For instance, pacemakers and defibrillators are capable of monitoring the heart rhythm. Pacemakers replace the natural pacemaker of the heart i.e. sinoatrial node (SA node) and defibrillator, monitors the heart rhythm and can prevent cardiac arrest. These devices come under Class II and some under Class III devices in the U.S. FDA medical devices listing and are subject to stringent regulations as they pose surgical risks during placement, bruising at surgical site, pain, and high risks due to implant failure. The active implantable medical devices market is dominated by few leading players such as Medtronic Plc., Abbott Laboratories, Boston Scientific Corporation, and Cochlear Ltd. accounting for over 70% of the market share.

Market Dynamics

Advancements in technology such as magnetic resonance imaging (MRI) compatible pacemakers and growing support in favor of use of such devices in cardiovascular and chronic pain diseases is expected to boost growth of the active implantable medical devices market. For instance, in November 2017, American Heart Association (AHA), the American College of Cardiology (ACC), and the Heart Rhythm Society (HRS) approved the use of subcutaneous implantable cardioverter defibrillator, (S-ICD), for the treatment of ventricular arrhythmias and to prevent cardiac arrest. Major manufacturers in the market are focusing on collaborations and mergers and acquisitions and are increasingly investing in research and development of implantable devices. For instance, merger of Sorin Group and Cyberonics to form LivaNova Plc in 2015. Furthermore, effectiveness of these devices in improving medical outcomes of cardiovascular and chronic pain diseases, absence of effective alternatives to these devices and continuous product launches is expected to fuel growth of the market.

Key features of the study:

  • This report provides in-depth analysis of active implantable medical devices market and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017–2025), considering 2016 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global active implantable medical devices market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Cochlear Limited, Boston Scientific Corporation, Medtronic Plc, LivaNova Plc, Abbott laboratories, Sonova Holding AG, William Demant holding A/S, Nurotron Biotechnology Co., Ltd., and Med-EL
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global active implantable medical devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the active implantable medical devices market

Detailed Segmentation:

  • Global Active Implantable Medical Devices Market, By Product Type:
    • Pacemakers
    • Implantable Cardioverter Defibrillators (ICD)
    • Cardiac Resynchronization Therapy Devices (CRT-D)
    • Neurostimulators
    • Drug Infusion Pumps
    • Implantable Loop Recorders
    • Cochlear Implants
    • Others
  • Global Active Implantable Medical Devices Market, By Geography:
    • North America
      • By Product Type:
        • Pacemakers
        • Implantable Cardioverter Defibrillators (ICD)
        • Cardiac Resynchronization Therapy Devices (CRT-D)
        • Neurostimulators
        • Drug Infusion Pumps
        • Implantable Loop Recorders
        • Cochlear Implants
        • Others
      • By Country:
        • U.S.
        • Canada
    • Europe
      • By Product Type:
        • Pacemakers
        • Implantable Cardioverter Defibrillators (ICD)
        • Cardiac Resynchronization Therapy Devices (CRT-D)
        • Neurostimulators
        • Drug Infusion Pumps
        • Implantable Loop Recorders
        • Cochlear Implants
        • Others
      • By Country:
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type:
        • Pacemakers
        • Implantable Cardioverter Defibrillators (ICD)
        • Cardiac Resynchronization Therapy Devices (CRT-D)
        • Neurostimulators
        • Drug Infusion Pumps
        • Implantable Loop Recorders
        • Cochlear Implants
        • Others
      • By Country:
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • By Product Type:
        • Pacemakers
        • Implantable Cardioverter Defibrillators (ICD)
        • Cardiac Resynchronization Therapy Devices (CRT-D)
        • Neurostimulators
        • Drug Infusion Pumps
        • Implantable Loop Recorders
        • Cochlear Implants
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East
      • By Product Type:
        • Pacemakers
        • Implantable Cardioverter Defibrillators (ICD)
        • Cardiac Resynchronization Therapy Devices (CRT-D)
        • Neurostimulators
        • Drug Infusion Pumps
        • Implantable Loop Recorders
        • Cochlear Implants
        • Others
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type:
        • Pacemakers
        • Implantable Cardioverter Defibrillators (ICD)
        • Cardiac Resynchronization Therapy Devices (CRT-D)
        • Neurostimulators
        • Drug Infusion Pumps
        • Implantable Loop Recorders
        • Cochlear Implants
        • Others
      • By Country:
        • Central Africa
        • South Africa
        • North Africa
  • Company Profiles
    • Cochlear Limited*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • Boston Scientific Corporation
    • Medtronic Plc.
    • LivaNova Plc.
    • Abbott Laboratories
    • Sonova Holding AG
    • William Demant holding A/S
    • Nurotron Biotechnology Co. Ltd.
    • Med-EL

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Pricing Analysis
    • PEST Analysis
    • PORTER’s Five Forces Analysis
    • Regulatory Scenario
    • Technological Evolution
  4. Global Active Implantable Medical Devices Market, By Product Type, 2015–2025 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, 2016–2025
      • Segment Trends
    • Pacemakers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
    • Implantable Cardioverter Defibrillators (ICD)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
    • Cardiac Resynchronization Therapy Devices (CRT-D)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
    • Neurostimulators
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
    • Drug Infusion Pumps
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
    • Implantable Loop Recorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
    • Cochlear Implants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2015–2025, (US$ Mn)
  5. Global Active Implantable Medical Devices Market, By Region, 2015–2025 (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, For Regions, 2016–2025
    • North America
      • Market Size and Forecast, By Product Type, 2017–2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2017–2025 (US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Product Type, 2017–2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2017–2025 (US$ Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2017–2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2017–2025 (US$ Mn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of APAC
    • Latin America
      • Market Size and Forecast, By Product Type, 2017–2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2017–2025 (US$ Mn)
        • Brazil
        • Mexico
        • Rest of Latin America
    • Africa
      • Market Size and Forecast, By Product Type, 2017–2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2017–2025 (US$ Mn)
        • Central Africa
        • South Africa
        • North Africa
    • Middle East
      • Market Size and Forecast, By Product Type, 2017–2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2017–2025 (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
  6. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Cochlear Limited  
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Boston Scientific Corporation
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Medtronic Plc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • LivaNova Plc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Abbott Laboratories
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Sonova Holding AG
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • William Demant holding A/S
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Nurotron Biotechnology Co. Ltd.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Med-EL
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  7. Section
    • Research Methodology
    • About us and Sales Contact

*Browse 30 market data tables and 56 figures on "Active Implantable Medical Devices Market - Global forecast to 2025”.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.